Oct 19 (Reuters) - Shenzhen Chipscreen Biosciences Co Ltd
688321.SS :
* SHENZHEN CHIPSCREEN BIOSCIENCES CO LTD - ANNOUNCES NMPA NEW DRUG APPROVAL OF BILESSGLU (CHIGLITAZAR SODIUM TABLETS) FOR ( TYPE 2 DIABETES) IN CHINA
Source text for Eikon: ID:nPn2nXW6va Further company coverage: 688321.SS
((Reuters.Briefs@thomsonreuters.com;))